Head and Neck Squamous Cell Carcinoma (HNSCC) Active Not Recruiting Phase 2 Trials for DB00544 (Fluorouracil)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01154920Paclitaxel, Carboplatin and Cetuximab (PCC) With Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell CarcinomaTreatment